Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
CIAN HEALTHCARE TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
CIAN HEALTHCARE Mar-23 |
TEVA PHARMA Dec-13 |
CIAN HEALTHCARE/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 32 | 3,477 | - | |
Low | Rs | 12 | 3,020 | - | |
Sales per share (Unadj.) | Rs | 27.4 | 1,995.2 | - | |
Earnings per share (Unadj.) | Rs | 0.8 | 124.6 | - | |
Cash flow per share (Unadj.) | Rs | 3.0 | 285.9 | - | |
Dividends per share (Unadj.) | Rs | 0 | 109.11 | - | |
Avg Dividend yield | % | 0 | 3.4 | 0.0% | |
Book value per share (Unadj.) | Rs | 23.0 | 2,216.3 | - | |
Shares outstanding (eoy) | m | 25.00 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.8 | 1.6 | 49.1% | |
Avg P/E ratio | x | 27.0 | 26.1 | 103.7% | |
P/CF ratio (eoy) | x | 7.4 | 11.4 | 64.7% | |
Price / Book Value ratio | x | 1.0 | 1.5 | 65.1% | |
Dividend payout | % | 0 | 87.5 | 0.0% | |
Avg Mkt Cap | Rs m | 549 | 2,754,567 | 0.0% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 89 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,645.0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,351.7 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 686 | 1,691,953 | 0.0% | |
Other income | Rs m | 6 | 0 | - | |
Total revenues | Rs m | 692 | 1,691,953 | 0.0% | |
Gross profit | Rs m | 131 | 463,342 | 0.0% | |
Depreciation | Rs m | 54 | 136,762 | 0.0% | |
Interest | Rs m | 63 | 33,233 | 0.2% | |
Profit before tax | Rs m | 20 | 293,347 | 0.0% | |
Minority Interest | Rs m | 0 | 1,333 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,566 | -0.0% | |
Tax | Rs m | 0 | -3,581 | 0.0% | |
Profit after tax | Rs m | 20 | 105,695 | 0.0% | |
Gross profit margin | % | 19.1 | 27.4 | 69.8% | |
Effective tax rate | % | -1.9 | -1.2 | 159.2% | |
Net profit margin | % | 3.0 | 6.2 | 47.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 742 | 1,142,739 | 0.1% | |
Current liabilities | Rs m | 653 | 996,565 | 0.1% | |
Net working cap to sales | % | 13.1 | 8.6 | 151.5% | |
Current ratio | x | 1.1 | 1.1 | 99.2% | |
Inventory Days | Days | 94 | 91 | 103.8% | |
Debtors Days | Days | 1,396 | 96 | 1,455.3% | |
Net fixed assets | Rs m | 762 | 552,629 | 0.1% | |
Share capital | Rs m | 250 | 4,165 | 6.0% | |
Net worth | Rs m | 575 | 1,879,439 | 0.0% | |
Long term debt | Rs m | 294 | 865,133 | 0.0% | |
Total assets | Rs m | 1,605 | 3,866,655 | 0.0% | |
Interest coverage | x | 1.3 | 9.8 | 13.4% | |
Debt to equity ratio | x | 0.5 | 0.5 | 111.0% | |
Sales to assets ratio | x | 0.4 | 0.4 | 97.7% | |
Return on assets | % | 5.2 | 3.6 | 144.4% | |
Return on equity | % | 3.5 | 5.6 | 62.8% | |
Return on capital | % | 9.5 | 4.9 | 193.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 48 | 269,610 | 0.0% | |
From Investments | Rs m | 26 | -95,534 | -0.0% | |
From Financial Activity | Rs m | -74 | -323,415 | 0.0% | |
Net Cashflow | Rs m | 0 | -149,339 | 0.0% |
Compare CIAN HEALTHCARE With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US)
Compare CIAN HEALTHCARE With: FDC BDH INDUS. WALPAR NUTRITIONS LTD. GUFIC BIOSCIENCE J.B.CHEMICALS
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.